IGSB Core Faculty Robert Grossman appointed Chief Research Informatics Officer of the Division of the Biological Sciences
Department of Medicine and the College
Robert Grossman is a faculty member in the Section of Genetic Medicine, as well as the chief research informatics officer for the Division of the Biological Sciences. He is also a senior fellow in the Computation Institute and the Institute for Genomics and Systems Biology. His research group focuses on bioinformatics, data mining, cloud computing, data intensive computing, and related areas. He is also the founder of Open Data Group, which has provided strategic consulting and outsourced services in analytics since 2002, specializing in building predictive models over big data. His current research is focused on bioinformatics, especially developing systems, applications, and algorithms so that large datasets of genomics data can be integrated with phenotype information extracted from electronic medical records and analyzed to deepen our understanding of diseases.
Most recently, Grossman was a Pritzker Scholar at the University of Chicago in 2011; the overall winner, SC 09 Bandwidth Challenge for “Maximizing Bandwidth Utilization in Distributed Data Intensive Applications”; and first place winner, SC 08 Bandwidth Challenge for “Towards Global Scale Cloud Computing: Using Sector and Sphere on the Open Cloud Testbed.”
He serves on the NASA Advisory Council Information Technology Infrastructure Committee.
Grossman earned his PhD in applied mathematics at Princeton University and an AB in mathematics from Harvard University.
Latest News
IGSB Senior Fellow Janet Rowley wins the 2012 Japan Prize for Healthcare and Medical Technology
Janet Davison Rowley, MD, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at the University of Chicago, will share the 2012 Japan Prize for Healthcare and Medical Technology with Brian J. Druker, MD, from the Oregon Health and Science University, and Nicholas B. Lydon, PhD, formerly with Novartis. They were chosen for their roles in the development of the first precisely targeted anti-cancer drug, called imatinib (Gleevec®). Press Release
IGSB Fellow Habibul Ahsan receives named professorship
Habibul Ahsan, MD, MMedSc, professor in the departments of health studies, human genetics and medicine, director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medical Center and associate director of the University of Chicago Comprehensive Cancer Center, has been named a Louis Block Professor. Press Release
Top Japanese Scientist leaving government post to move to the University of Chicago Medical Center
“Dr. Nakamura has made major contributions to modern genetics and genomics,” said Kenneth Polonsky, MD, Dean of the Biological Sciences Division and the Pritzker School of Medicine at the University of Chicago. “We are extremely gratified by his interest in continuing his illustrious career at the University of Chicago.” Press Release